Clinical trial

Elacestrant in Preoperative Setting, a Window of Opportunity Study

NCT04797728

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-02-09

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2021-02-09Date precision: day

Registry last updated2022-10-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Hormone Receptor Positive Breast Carcinomaunresolved

Interventions

ElacestrantDRUG · verified · RxNorm: elacestrant

Sponsors & collaborators

SOLTI Breast Cancer Research Grouplead sponsor

Radius Health, Inc.collaborator

Mapped research locations

BarcelonaSpain2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04797728 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.